Earnings Feed
Start Free
Home/Filings/4/0001144204-13-040766
4//SEC Filing

Targeted Medical Pharma, Inc. 4

Accession 0001144204-13-040766

CIK 0001420030operating
View on SEC.govCompany Profile

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 7:41 PM ET

Size

85.8 KB

Accession

0001144204-13-040766

Insider Transaction Report

Form 4
Period: 2012-04-11
Targeted Medical Pharma, Inc.NONE
Shell William
DirectorCEO/Chief Scientific Officer10% Owner
Transactions
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-19$4.73/sh+4,000$18,920→ 398,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-05$2.10/sh+10,000$21,000→ 186,650 total(indirect: By Trust)
  • Award

    Option to Purchase Common Stock

    2013-03-07+150,000→ 150,000 total
    Exercise: $1.50From: 2013-03-07Exp: 2020-03-06→ Common Stock (150,000 underlying)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-26$4.15/sh+1,000$4,150→ 420,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-22$4.26/sh+2,500$10,650→ 53,659 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-19$4.35/sh+1,000$4,350→ 51,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-18$4.91/sh+13,500$66,285→ 394,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-17$4.65/sh+6,000$27,900→ 50,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-16$4.49/sh+32,000$143,680→ 350,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-15$4.97/sh+659$3,275→ 38,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-12$4.08/sh+16,200$66,096→ 279,599 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-09$2.31/sh+11,000$25,410→ 31,000 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-09$2.32/sh+21,500$49,880→ 215,650 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-08$2.14/sh+7,500$16,050→ 194,150 total(indirect: By Trust)
  • Award

    Warrants to Purchase Common Stock

    2012-07-05+95,000→ 95,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-07-05Exp: 2017-07-05→ Common Stock (95,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-05-02+150,000→ 150,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-05-02Exp: 2017-05-02→ Common Stock (150,000 underlying)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-15$4.51/sh+39,200$176,792→ 318,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-11$4.00/sh+1,000$4,000→ 36,500 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-10$3.85/sh+4,500$17,325→ 35,500 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-08$2.15/sh+1,000$2,150→ 20,000 total(indirect: By Trust)
  • Award

    Warrants to Purchase Common Stock

    2012-06-07+175,000→ 175,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-06-07Exp: 2017-06-07→ Common Stock (175,000 underlying)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-24$4.15/sh+4,000$16,600→ 416,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-23$4.25/sh+1,500$6,375→ 55,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-05$2.11/sh+4,000$8,440→ 19,000 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-23$4.15/sh+9,500$39,425→ 412,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-17$4.59/sh+30,500$139,995→ 381,299 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-16$4.47/sh+6,000$26,820→ 44,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-12$4.38/sh+1,000$4,380→ 37,500 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-11$3.94/sh+14,000$55,160→ 263,399 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-10$2.91/sh+12,149$35,354→ 249,399 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-10$3.82/sh+21,600$82,512→ 237,250 total(indirect: By Trust)
  • Conversion

    Common Stock, $.001 par value per share

    2013-06-04+584,795→ 639,954 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-22$4.32/sh+4,500$19,440→ 403,299 total(indirect: By Trust)
  • Award

    Warrants to Purchase Common Stock

    2012-05-24+220,000→ 220,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-05-24Exp: 2017-05-24→ Common Stock (220,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-04-19+100,000→ 100,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-04-19Exp: 2017-04-19→ Common Stock (100,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-04-11+250,000→ 250,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-04-11Exp: 2017-04-11→ Common Stock (250,000 underlying)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-25$4.01/sh+3,000$12,030→ 419,799 total(indirect: By Trust)
  • Award

    Warrants to Purchase Common Stock

    2012-06-21+220,000→ 220,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-06-21Exp: 2017-06-21→ Common Stock (220,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-05-25+190,000→ 190,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-05-25Exp: 2017-05-25→ Common Stock (190,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-05-10+110,000→ 110,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-05-10Exp: 2017-05-10→ Common Stock (110,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-04-26+200,000→ 200,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-04-26Exp: 2017-04-26→ Common Stock (200,000 underlying)
Elizabeth Charuvastra & William Shell Family Trust
10% Owner
Transactions
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-26$4.15/sh+1,000$4,150→ 420,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-25$4.01/sh+3,000$12,030→ 419,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-24$4.15/sh+4,000$16,600→ 416,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-23$4.25/sh+1,500$6,375→ 55,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-22$4.32/sh+4,500$19,440→ 403,299 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-12$4.08/sh+16,200$66,096→ 279,599 total(indirect: By Trust)
  • Award

    Warrants to Purchase Common Stock

    2012-05-10+110,000→ 110,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-05-10Exp: 2017-05-10→ Common Stock (110,000 underlying)
  • Conversion

    Common Stock, $.001 par value per share

    2013-06-04+584,795→ 639,954 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-23$4.15/sh+9,500$39,425→ 412,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-22$4.26/sh+2,500$10,650→ 53,659 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-19$4.73/sh+4,000$18,920→ 398,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-16$4.49/sh+32,000$143,680→ 350,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-15$4.97/sh+659$3,275→ 38,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-12$4.38/sh+1,000$4,380→ 37,500 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-15$4.51/sh+39,200$176,792→ 318,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-10$3.85/sh+4,500$17,325→ 35,500 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-08$2.14/sh+7,500$16,050→ 194,150 total(indirect: By Trust)
  • Award

    Option to Purchase Common Stock

    2013-03-07+150,000→ 150,000 total
    Exercise: $1.50From: 2013-03-07Exp: 2020-03-06→ Common Stock (150,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-06-21+220,000→ 220,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-06-21Exp: 2017-06-21→ Common Stock (220,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-07-05+95,000→ 95,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-07-05Exp: 2017-07-05→ Common Stock (95,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-04-19+100,000→ 100,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-04-19Exp: 2017-04-19→ Common Stock (100,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-05-25+190,000→ 190,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-05-25Exp: 2017-05-25→ Common Stock (190,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-05-02+150,000→ 150,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-05-02Exp: 2017-05-02→ Common Stock (150,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-06-07+175,000→ 175,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-06-07Exp: 2017-06-07→ Common Stock (175,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-05-24+220,000→ 220,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-05-24Exp: 2017-05-24→ Common Stock (220,000 underlying)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-17$4.59/sh+30,500$139,995→ 381,299 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-08$2.15/sh+1,000$2,150→ 20,000 total(indirect: By Trust)
  • Award

    Warrants to Purchase Common Stock

    2012-04-26+200,000→ 200,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-04-26Exp: 2017-04-26→ Common Stock (200,000 underlying)
  • Award

    Warrants to Purchase Common Stock

    2012-04-11+250,000→ 250,000 total(indirect: By Trust)
    Exercise: $1.00From: 2012-04-11Exp: 2017-04-11→ Common Stock (250,000 underlying)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-17$4.65/sh+6,000$27,900→ 50,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-11$3.94/sh+14,000$55,160→ 263,399 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-10$3.82/sh+21,600$82,512→ 237,250 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-09$2.31/sh+11,000$25,410→ 31,000 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-19$4.35/sh+1,000$4,350→ 51,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-18$4.91/sh+13,500$66,285→ 394,799 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-16$4.47/sh+6,000$26,820→ 44,159 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-11$4.00/sh+1,000$4,000→ 36,500 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-10$2.91/sh+12,149$35,354→ 249,399 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-05$2.11/sh+4,000$8,440→ 19,000 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-05$2.10/sh+10,000$21,000→ 186,650 total(indirect: By Trust)
  • Purchase

    Common Stock, $.001 par value per share

    2013-04-09$2.32/sh+21,500$49,880→ 215,650 total(indirect: By Trust)
Footnotes (25)
  • [F1]On June 4, 2013, William Shell Survivor's Trust was issued 584,795 shares of common stock as repayment for an aggregate of $1,000,000 notes payable.
  • [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.79 per share.
  • [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.20 to $5.00 per share.
  • [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.25 to $5.00 per share.
  • [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $4.40 per share.
  • [F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $4.00 per share.
  • [F15]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $3.45 per share.
  • [F16]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $4.00 per share.
  • [F17]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.50 per share.
  • [F18]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.14 to $2.15 per share.
  • [F19]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.09 to $2.12 per share.
  • [F2]Common stock and warrants are held by Willliam Shell Survivor's Trust.
  • [F20]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.25 to $4.30 per share.
  • [F21]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.55 to $4.79 per share.
  • [F22]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.38 to $4.90 per share.
  • [F23]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.10 per share.
  • [F24]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.50 per share.
  • [F25]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.12 per share.
  • [F3]Common stock is held by Elizabeth Charuvastra Exemption Trust. William E. Shell is voluntarily filing on behalf of the Elizabeth Charuvastra Exemption Trust and disclaims any and all pecuniary interest in the Elizabeth Charuvastra Exemption Trust.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.05 per share.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.10 to $4.20 per share.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $4.25 per share.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.35 per share.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.85 per share.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $5.10 per share.

Documents

1 file

Issuer

Targeted Medical Pharma, Inc.

CIK 0001420030

→
Entity typeoperating

Related Parties

1
  • filerCIK 0001420030

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 7:41 PM ET
Size
85.8 KB
View on SEC.gov